W badaniu SCALE (56 tygodni, BMI 30 lub 27 z powikaniami) liraglutyd 3,0 mg spowodowa redukcj masy ciaa o ok
Just a note: These medications are generally avoided in patients with a history of medullary thyroid carcinoma or MEN2, due to some safety signals in the trials where they were studied
You may notice improved hydration and glow shortly after treatment
Treat your body right and youll enjoy smoother, longer-lasting results
Author contributions YK: Conceptualization, Data curation, Investigation, Methodology, Project administration, Validation, Writing original draft, Writing review & editing
To minimize confounders, the groups were matched based on numerous demographic and chronic disease variables